Emergent BioSolutions, Inc. (EBS)
10.99
+0.04
(+0.37%)
USD |
NYSE |
Jan 16, 16:00
11.01
+0.02
(+0.18%)
After-Hours: 20:00
Emergent BioSolutions Market Cap: 577.19M for Jan. 16, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Boston Scientific Corp. | 130.56B |
| Eli Lilly & Co. | 929.39B |
| Penumbra, Inc. | 13.76B |
| Disc Medicine, Inc. | 2.678B |
| Black Diamond Therapeutics, Inc. | 145.86M |
Market Cap Related Metrics
| PE Ratio | 8.493 |
| PS Ratio | 0.7739 |
| Price to Book Value | 0.9909 |
| Price to Free Cash Flow | 436.07 |
| Price | 10.99 |
| Earnings Yield | 11.77% |
| Operating PE Ratio | 5.263 |
| Normalized PE Ratio | 8.705 |